ARSVX Financial Statements & Analysis
Complete financial statements for ARSVX including income statement, balance sheet, and cash flow statement. Analyze ARSVX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
13.5% ↑
Net Income
40.1% ↑
Gross Margin
-0.7% ↓
Operating Margin
25.2% ↑
Balance Sheet
Current Ratio
10.3% ↑
Debt to Equity
-10.2% ↑
Asset Turnover
5.3% ↑
Cash Flow
Operating Cash Flow
26.2% ↑
Net Cash Flow
68.8% ↑
Free Cash Flow
30.3% ↑
Cash Flow to Debt
26.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2022 | 2023 | Change | Impact |
|---|---|---|---|---|
| Revenue | 371.77M | 421.88M | 13.5% | |
| Gross Profit | 315.64M | 355.51M | 12.6% | |
| Operating Income | 49.96M | 70.99M | 42.1% | |
| Net Income | 16.71M | 23.41M | 40.1% | |
| EPS | 0.09 | 0.13 | 44.4% | |
| EBITDA | 69.42M | 87.37M | 25.9% | |
| Gross Margin | 84.90% | 84.27% | 0.7% | |
| Operating Margin | 13.44% | 16.83% | 25.2% | |
| Net Income Margin | 4.49% | 5.55% | 23.5% | |
| R&D Expenses | 65.96M | 80.02M | 21.3% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 421.88M | 371.77M | 346.46M | — | — |
| Gross Profit | 355.51M | 315.64M | 299.78M | — | — |
| Operating Income | 70.99M | 49.96M | 33.75M | — | — |
| Net Income | 23.41M | 16.71M | 113.00K | — | — |
| EPS | 0.13 | 0.09 | 0.00 | — | — |
| EBITDA | 87.37M | 69.42M | 59.57M | — | — |
| Gross Margin | 84.27% | 84.90% | 86.53% | — | — |
| Operating Margin | 16.83% | 13.44% | 9.74% | — | — |
| Net Income Margin | 5.55% | 4.49% | 0.03% | — | — |
| R&D Expenses | 80.02M | 65.96M | 59.71M | — | — |
Financial Metrics
Want to dive deeper into ARSVX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics